Note to the editor
AJ Vaccines Group is part of a solid business conglomerate and is based in Copenhagen, Denmark. We develop and manufacture vaccines against serious infectious diseases such as tetanus, diphtheria, tuberculosis, pertussis (whooping cough) and polio. In addition, the Group manufactures Tuberculin for screening and diagnosis of high-risk patients for infection with TB, and BCG Culture (Danish strain 1331) for the standard treatment for intermediate and high-risk non-muscle invasive bladder cancer. Our affiliate offices in Malaysia and Singapore focus on in-licensing vaccines such as cholera and influenza vaccines. The company has 600+ employees.
See more at www.ajvaccines.com.